Page 5 - Benjamint Dake News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Benjamint dake. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Benjamint Dake Today - Breaking & Trending Today

Benjamin T. Dake Sells 10,283 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Stock

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) insider Benjamin T. Dake sold 10,283 shares of the firm’s stock in a transaction on Monday, August 7th. The shares were sold at an average price of $15.52, for a total value of $159,592.16. Following the transaction, the insider now owns 1,291 shares in the company, valued […] ....

United States , Benjamint Dake , Tower Research Capital , Cheyne Capital Management United Kingdom , Aerovate Therapeutics Inc , Swiss National Bank , Aerovate Therapeutics , Get Free Report , National Bank , Capital Management United Kingdom , Research Capital , Strs Ohio , Aerovate Therapeutics Daily , Nasdaq Avte , Insider Trading , Nsider Trades ,

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Update

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Update
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Benjamint Dake , Ralph Niven , Tower Research Capital , Aerovate Therapeutics Inc , Barclays Plc , Aerovate Therapeutics , Get Free Report , Research Capital , Aerovate Therapeutics Daily ,

Insider Selling: Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Insider Sells 10,283 Shares of Stock

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Free Report) insider Benjamin T. Dake sold 10,283 shares of the stock in a transaction that occurred on Thursday, July 6th. The stock was sold at an average price of $16.66, for a total value of $171,314.78. Following the sale, the insider now directly owns 1,291 shares of the company’s […] ....

United States , Benjamint Dake , Aerovate Therapeutics Company Profile , York Mellon Corp , American International Group Inc , Blackrock Inc , Jpmorgan Chase Co , Aerovate Therapeutics Inc , Vanguard Group Inc , Aerovate Therapeutics , Free Report , New York Mellon Corp , American International Group , International Group , Aerovate Therapeutics Daily , Nasdaq Avte , Insider Trading , Nsider Trades ,

Short Interest in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Expands By 5.3%

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Rating) was the recipient of a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 961,900 shares, an increase of 5.3% from the May 15th total of 913,900 shares. Based on an average trading volume of 78,000 shares, the […] ....

United States , Benjamint Dake , Ralph Niven , Vr Adviser , Aerovate Therapeutics Inc , Citadel Advisors , Securities Exchange Commission , Crossover Management , Atlas Venture Life Science Advisors , Aerovate Therapeutics , Get Rating , Exchange Commission , Asset Management , Venture Life Science Advisors , Therapeutics Trading Down , Aerovate Therapeutics Daily ,

Eversept Partners LP Purchases Shares of 91,252 Aerovate Therapeutics, Inc. (NASDAQ:AVTE)

Eversept Partners LP acquired a new position in shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Rating) in the 4th quarter, Holdings Channel reports. The fund acquired 91,252 shares of the company’s stock, valued at approximately $2,674,000. Other institutional investors also recently modified their holdings of the company. Cormorant Asset Management LP grew its stake […] ....

United States , Benjamint Dake , Timothyp Noyes , Ghost Tree Capital , Aerovate Therapeutics Company Profile , Holdings Channel , Aerovate Therapeutics Inc , Vr Adviser , Eversept Partners , Aerovate Therapeutics , Get Rating , Asset Management , Tree Capital , Visit Holdingschannel , Aerovate Therapeutics Daily ,